Caption Management’s Teva Pharmaceuticals TEVA Stock Holding History

Caption Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.3M	Buy	+674,500	New	+$21.7M	0.12%	183
2025 Q2	–	Sell	-662,300	Closed	-$10.2M	–	1887
2025 Q1	$10.2M	Buy	662,300 +117,100	+21%	+$2.09M	0.1%	203
2024 Q4	$12M	Buy	545,200 +370,200	+212%	+$6.73M	0.11%	152
2024 Q3	$3.15M	Buy	+175,000	New	+$3.06M	0.05%	429
2023 Q4	–	Sell	-402,700	Closed	-$4.11M	–	1671
2023 Q3	$4.11M	Buy	402,700 +8,600	+2%	+$80.1K	0.06%	370
2023 Q2	$2.97M	Buy	+394,100	New	+$3.2M	0.05%	402
2023 Q1	–	Sell	-1,976,000	Closed	-$18M	–	1544
2022 Q4	$18M	Hold	1,976,000	–	–	0.28%	80
2022 Q3	$15.9M	Hold	1,976,000	–	–	0.22%	89
2022 Q2	$14.9M	Hold	1,976,000	–	–	0.2%	110
2022 Q1	$18.6M	Hold	1,976,000	–	–	0.22%	93
2021 Q4	$15.8M	Buy	+1,976,000	New	+$17.8M	0.18%	140
2021 Q3	–	Sell	-50,000	Closed	-$495K	–	1801
2021 Q2	$495K	Hold	50,000	–	–	0.01%	1040
2021 Q1	$576K	Buy	+50,000	New	+$573K	0.01%	783
2020 Q1	–	Sell	-75,000	Closed	-$735K	–	1067
2019 Q4	$735K	Buy	+75,000	New	+$670K	0.02%	560
2019 Q2	–	Sell	-25,000	Closed	-$391K	–	824
2019 Q1	$391K	Sell	25,000 -333,400	-93%	-$5.88M	0.02%	454
2018 Q4	$5.53M	Hold	358,400	–	–	0.44%	66
2018 Q3	$7.72M	Buy	+358,400	New	+$8.32M	0.43%	59
2018 Q1	–	Sell	-394,800	Closed	-$7.48M	–	323
2017 Q4	$7.48M	Buy	+394,800	New	+$5.94M	0.78%	44

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caption Management's TEVA Position: Q1 2026 in Review

Caption Management increased its Teva Pharmaceuticals (TEVA) stake by 331% in Q1 2026, buying an estimated $6.92M and bringing the position to 280,058 shares worth $8.44M. The position accounts for 0.05% of the portfolio, ranked #376.

Caption Management first reported a position in TEVA in Q4 2018 and has held it in 15 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Caption Management held 280,058 shares of Teva Pharmaceuticals worth $8.44M as of Q1 2026.
Caption Management bought 215,058 Teva Pharmaceuticals shares in Q1 2026, an estimated $6.92M.
Teva Pharmaceuticals made up 0.05% of Caption Management's portfolio in Q1 2026, its #376 holding.
Caption Management first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 15 quarters since.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.